Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Associatie amyloïdpathologie en myeline bij preklinische Alzheimer
jan 2017 | Dementie